Misra M, Rodriguez R E, Kasprzak K S
Laboratory of Comparative Carcinogenesis, National Cancer Institute, Frederick Cancer Research Facility, Frederick, MD 21701.
Toxicology. 1990 Oct;64(1):1-17. doi: 10.1016/0300-483x(90)90095-x.
Lipid peroxidation (LPO) and alterations in cellular systems protecting against oxidative damage were determined in the liver, kidney and skeletal muscle of male F344/NCr rats, 1 h to 3 days after a single intraperitoneal (i.p.) injection of 107 mumol nickel(II)acetate per kg body weight. At 3 h, when tissue nickel concentrations were highest, the following significant (at least, P less than 0.05) effects were observed: in kidney, increased LPO (by 43%), increased renal iron (by 24%), decreased catalase (CAT) and glutathione peroxidase (GSH-Px) activities (both by 15%), decreased glutathione (GSH) concentration (by 20%), decreased glutathione reductase (GSSG-R) activity (by 10%), and increased glutathione-S-transferase (GST) activity (by 44%); the activity of superoxide dismutase (SOD) and gamma-glutamyl transferase (GGT), as well as copper concentration, were not affected. In the liver, nickel effects included increased LPO (by 30%), decreased CAT and GSH-Px activities (both by 15%), decreased GSH level (by 33%), decreased GSSG-R activity (by 10%) and decreased GST activity (by 35%); SOD, GGT, copper, and iron remained unchanged. In muscle, nickel treatment decreased copper content (by 43%) and the SOD activity (by 30%) with no effects on other parameters. In blood, nickel had no effect on CAT and GSH-Px, but increased the activities of alanine-(ALT) and aspartate-(AST) transaminases to 330% and 240% of the background level, respectively. In conclusion, nickel treatment caused profound cell damage as indicated by increased LPO in liver and kidney and leakage of intracellular enzymes, ALT and AST to the blood. The time pattern of the resulting renal and hepatic LPO indicated a possible contribution to its magnitude from an increased concentration of nickel and concurrent inhibition of CAT, GSH-Px and GSSG-R, but not from increased iron or copper levels. The oxidative damage expressed as LPO was highest in the kidney and lowest in the muscle, which concurs with the corresponding ranking of nickel uptake by these tissues.
在雄性F344/NCr大鼠腹腔注射每千克体重107微摩尔醋酸镍(II)后1小时至3天,测定其肝脏、肾脏和骨骼肌中的脂质过氧化(LPO)以及细胞系统中抗氧化损伤的变化。在3小时时,当组织镍浓度最高时,观察到以下显著(至少P小于0.05)效应:在肾脏中,LPO增加(43%),肾脏铁含量增加(24%),过氧化氢酶(CAT)和谷胱甘肽过氧化物酶(GSH-Px)活性降低(均为15%),谷胱甘肽(GSH)浓度降低(20%),谷胱甘肽还原酶(GSSG-R)活性降低(10%),谷胱甘肽-S-转移酶(GST)活性增加(44%);超氧化物歧化酶(SOD)和γ-谷氨酰转移酶(GGT)的活性以及铜浓度不受影响。在肝脏中,镍的影响包括LPO增加(30%),CAT和GSH-Px活性降低(均为15%),GSH水平降低(33%),GSSG-R活性降低(10%),GST活性降低(35%);SOD、GGT、铜和铁保持不变。在肌肉中,镍处理使铜含量降低(43%),SOD活性降低(30%),对其他参数无影响。在血液中,镍对CAT和GSH-Px无影响,但使丙氨酸转氨酶(ALT)和天冬氨酸转氨酶(AST)的活性分别增加到背景水平的330%和240%。总之,镍处理导致了严重的细胞损伤,表现为肝脏和肾脏中LPO增加以及细胞内酶ALT和AST泄漏到血液中。肾脏和肝脏LPO的时间模式表明,镍浓度增加以及同时抑制CAT、GSH-Px和GSSG-R可能对其程度有贡献,但不是由于铁或铜水平增加。以LPO表示的氧化损伤在肾脏中最高,在肌肉中最低,这与这些组织对镍的摄取相应排名一致。